Treatment outcomes in 1p19q co-deleted/partially deleted gliomas.
Authors
McNamara, Mairéad GJiang, H
Lim-Fat, M
Sahebjam, S
Kiehl, T
Karamchandani, J
Coire, C
Chung, C
Millar, B
Laperriere, N
Mason, W
Affiliation
Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, CanadaIssue Date
2017-05
Metadata
Show full item recordAbstract
Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma.Citation
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas. 2017, 44 (3):288-294 Can J Neurol SciJournal
The Canadian Journal of Neurological SciencesDOI
10.1017/cjn.2016.420PubMed ID
28488951Type
ArticleLanguage
enISSN
0317-1671ae974a485f413a2113503eed53cd6c53
10.1017/cjn.2016.420